Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe

Article type: Research Article

Authors: Morrison, P.J. | Steel, C.M. | Vasen, H.F.A. | Eccles, D. | Evans, D.G.R. | Møller, P. | Hodgson, S. | Stoppa-Lyonnet, D. | Chang-Claude, J. | Caligo, M. | Olah, E. | Haites, N.E. | Nevin, N.C.

Affiliations: Northern Ireland Regional Medical Genetics Centre, Belfast City Hospital Trust, Belfast, BT9 7AB, UK | School of Biomedical Sciences, University of St. Andrews, Scotland, UK | Foundation for the Detection of Hereditary Tumours, c/o University Hospital, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands | Department of Human Genetics, Princess Ann Hospital, Southampton SO16 5YA, UK | Department of Medical Genetics, St Mary's Hospital, Manchester, UK | Unit of Medical Genetics, The Norwegian radium Hospital, N-0310 Oslo, Norway | Division of Medical and Molecular Genetics, Guy's Hospital, London Bridge, London SE1 9RT, UK | Unité de Génétique Oncologique Institut Curie - Section Médicale 26, rue d'Ulm 75231 Paris Cedex 05 France | Division of Epidemiology, German Cancer Research Centre, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany | Institute of Pathology, University of Pisa, via Roma, 57,56126 Pisa, Italy | Department of Molecular Biology, National Institute of Oncology, H-1525 Budapest, Hungary | Department of Medicine and Therapeutics (Medical Genetics), University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, UK

Note: [] Correspondence: Dr. P.J. Morrison, Northern Ireland Regional Medical Genetics Centre, Belfast City Hospital Trust, Belfast BT9 7AB, UK, Tel: +44 1232 329241 Ext. 2764, Fax: +44 1232 236911, E-mail: [email protected]

Keywords: insurance, genetic testing, Europe, guidelines, breast & ovarian cancer

Journal: Disease Markers, vol. 15, no. 1-3, pp. 159-165, 1999